This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Clostrabio, The University of Chicago. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: The Innovative Contributions of Riyue Bao
Introduction
Riyue Bao is a prominent inventor based in Chicago, IL (US), known for his significant contributions to the field of immunotherapy. With a total of 2 patents, he has made strides in developing methods and compositions that address infectious, autoimmune, and allergic diseases.
Latest Patents
Riyue Bao's latest patents include groundbreaking work titled "METHODS AND COMPOSITIONS FOR TREATING INFECTIOUS, AUTOIMMUNE, AND ALLERGIC DISEASE." This patent focuses on microbiome biomarkers that can predict immunotherapy responsiveness. The compositions and methods described utilize the microbiome's characteristics to determine a subject's responsiveness or resistance to immunotherapy, particularly anti-PD1/PD-L1 therapies. By analyzing the microbiome's microflora, the patent outlines ways to enhance a subject's responsiveness to various immunotherapies and co-therapies.
Career Highlights
Throughout his career, Riyue Bao has worked with esteemed institutions, including the University of Chicago and Clostrabio. His research has been pivotal in advancing the understanding of how microbiome factors can influence treatment outcomes in immunotherapy.
Collaborations
Riyue Bao has collaborated with notable professionals in his field, including Jason Luke and Thomas F. Gajewski. These collaborations have further enriched his research and contributed to the development of innovative therapeutic strategies.
Conclusion
Riyue Bao's work exemplifies the intersection of microbiome research and immunotherapy, showcasing his commitment to advancing medical science. His patents and collaborations highlight his role as a key innovator in the field.